News
1 minute read

MBHB Partner Kevin Noonan Authors DDN News Article Entitled, “Patent Docs: Supreme Court expansion of patent-limiting doctrine puts branded drugs at risk”

Kevin E. Noonan, Ph.D.February 13, 2018

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authors DDN News article entitled, “Patent Docs: Supreme Court expansion of patent-limiting doctrine puts branded drugs at risk”. The U.S. Supreme Court at the end of the past term handed down a decision, Impression Products, Inc. v. Lexmark International, Inc., that greatly expands the doctrine of patent exhaustion. view the article